# New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Source: https://onco.cc/trials/nct04564157/  
OnCo record `nct04564157` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of carboplatin, paclitaxel / nab-paclitaxel and nivolumab in lung cancer, run by Fundación GECP, active but no longer recruiting.

## Summary

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy is a phase 3, randomised interventional study registered as NCT04564157 by Fundación GECP, with a registry enrolment figure of 210 participants, started 2021-01-13 and due to reach its primary completion in 2030-04-01. Interventions recorded: Carboplatin; Paclitaxel; Nivolumab. Conditions listed: Non-Small Cell Lung Cancer; Adjuvant Chemotherapy. Primary outcome: The disease-free survival. Lung eligibility wording from the registry: "Patients diagnosed of primary non-small cell lung cancer, histologically confirmed". Sites: Spain. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-25
- Also known as: NADIM-ADJUVANT
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT04564157
- Phase: 3
- Setting: A Phase III Clinical Trial of Adjuvant Chemotherapy vs Chemoimmunotherapy for Stage IB-IIIA Completely Resected Non-small Cell Lung Cancer (NSCLC) Patients.
- Sponsor: Fundación GECP
- Enrolled: 210

## Sources

- ClinicalTrials.gov NCT04564157: https://clinicaltrials.gov/study/NCT04564157

## Connected records

- cancers: [Resectable stage I to III non-small-cell lung cancer](https://onco.cc/cancers/resectable-nsclc/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Nivolumab](https://onco.cc/drugs/nivolumab/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct04564157.json